| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/03/2003 | CA2451839A1 Pharmaceutical compositions comprising peptides and permeation enhancers |
| 01/03/2003 | CA2451434A1 Method and device for producing compression coated tablets |
| 01/03/2003 | CA2451383A1 Regioselectively reticulated polysaccharides |
| 01/03/2003 | CA2451248A1 Composition comprising glycosaminoglycans and hyaluronidase inhibitors for the treatment of arthritic joints |
| 01/03/2003 | CA2451245A1 Liposomal encapsulation of glycosaminoglycans for the treatment of arthritic joints |
| 01/03/2003 | CA2451239A1 Antibodies against tumor-associated antigenic taget (tat) polypeptides |
| 01/03/2003 | CA2451188A1 Exponential pattern recognition based cellular targeting, compositions, methods and anticancer applications |
| 01/03/2003 | CA2451146A1 Method for manufacturing of free-flowing powder containing water-dispersible sterols |
| 01/03/2003 | CA2451091A1 A method for preparation of vesicles loaded with biological material and different uses thereof |
| 01/03/2003 | CA2450957A1 Pharmaceutical compositions of dispersions of drugs and neutral polymers |
| 01/03/2003 | CA2450950A1 Chemically-modified progenipoietin conjugates |
| 01/03/2003 | CA2450762A1 Pharmaceutical compositions comprising low-solubility and/or acid-sensitive drugs and neutralized acidic polymers |
| 01/03/2003 | CA2450748A1 Pharmaceutical compositions containing polymer and drug assemblies |
| 01/03/2003 | CA2450742A1 Pediatric formulation of gatifloxacin |
| 01/03/2003 | CA2450449A1 Pharmaceutical formulation |
| 01/03/2003 | CA2450001A1 Stable pharmaceutical compositions containing pravastatin |
| 01/03/2003 | CA2449998A1 Stable controlled release pharmaceutical compositions containing pravastatin |
| 01/03/2003 | CA2449439A1 Particles for inhalation having rapid release properties |
| 01/03/2003 | CA2446205A1 Water-soluble antibiotic comprising an amino sugar, in the form of a polysaccharide conjugate |
| 01/02/2003 | US20030004325 Stability; nuclease resistance |
| 01/02/2003 | US20030004308 Anticoagulants |
| 01/02/2003 | US20030004241 Use of copolymers based on acrylamidoalkylsulfonic acids as thickeners in preparations comprising organic solvents |
| 01/02/2003 | US20030004211 Carbohydrate modifying agent and drinks containing the modifying agent |
| 01/02/2003 | US20030004210 Coupling to cell binding agent; killing cells |
| 01/02/2003 | US20030004209 Anti-angiogenic compositions and methods of use |
| 01/02/2003 | US20030004206 Hypotensive agents; cardiovascular disorders |
| 01/02/2003 | US20030004205 Carvedilol-hydrophilic solutions |
| 01/02/2003 | US20030004182 Method for manufacturing a low dose pharmaceutical composition having uniform drug distribution and potency |
| 01/02/2003 | US20030004178 Synergistic mixture |
| 01/02/2003 | US20030004177 Abuse-resistant opioid dosage form |
| 01/02/2003 | US20030004155 Pharmaceutical compositions |
| 01/02/2003 | US20030004135 Composition and method for the treatment of dysglucaemia |
| 01/02/2003 | US20030004133 Wound healing agents, antiulcer agents |
| 01/02/2003 | US20030004121 Supplying hybrid protein to central nervous system |
| 01/02/2003 | US20030004118 Antibiotic/benzoyl peroxide dispenser |
| 01/02/2003 | US20030004110 Therapeutic compositions and methods for enhancing angiogenesis |
| 01/02/2003 | US20030004100 Method of modifying the release profile of sustained release compositions |
| 01/02/2003 | US20030004097 Methods and compositions for inducing autoimmunity in the treatment of cancers |
| 01/02/2003 | US20030004096 Polypeptide mixture containing preservative, surfactant and stabilizer |
| 01/02/2003 | US20030004077 Environmentally desirable for use as refrigerants, aerosol propellants, metered dose inhalers, blowing agents for polymer foam, heat transfer media, and gaseous dielectrics |
| 01/02/2003 | US20030003212 Taste modifiers |
| 01/02/2003 | US20030003163 For restoration and maintenance of gingival and periodontal health; antiplaque/antitar agents; mouthwash |
| 01/02/2003 | US20030003151 Chemical delivery device |
| 01/02/2003 | US20030003150 System for osmotic delivery of pharmaceutically active agents |
| 01/02/2003 | US20030003145 Comprises micronized N-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3 -carboxamide |
| 01/02/2003 | US20030003143 Lipidic microparticles linked to multiple proteins |
| 01/02/2003 | US20030003141 Contacting a blood vessel wall cell with an A beta 40 inhibitor, such that cerebral amyloid angiopathy is inhibited |
| 01/02/2003 | US20030003139 Transdermal system that contains a new highly potent gestagen |
| 01/02/2003 | US20030003133 Use of milk and milk- related products as a carrier or delivery vehicle for allergens in the process of oral tolerance induction and prevent allergic conditions |
| 01/02/2003 | US20030003131 Method for manufacture of free-flowing powder containing water-dispersible sterols |
| 01/02/2003 | US20030003117 Hydrolyzed whole egg products & related methods |
| 01/02/2003 | US20030003114 Hexosaminidase covalently attached to a cancer cell targeting ligand; improves selectively of the hexosaminidase for tumor cells |
| 01/02/2003 | US20030003112 Avipox virus containing foreign DNA from porcine reproductive and respiratory syndrome virus; immunological compositions containing the recombinant poxvirus for inducing an immunological response in a host animal |
| 01/02/2003 | US20030003107 Topical compositions containing probiotic bacillus bacteria, spores, and extracellular products and uses thereof |
| 01/02/2003 | US20030003105 Comprising lecithin and a polymer, preferably polyacrylic acid |
| 01/02/2003 | US20030003102 Morpholino imaging and therapy |
| 01/02/2003 | US20030003095 Activated carbon for preventing pregnancy and sexually transmitted disease |
| 01/02/2003 | US20030003094 Compound which disrupts microtubule function and polymeric carrier, with proviso that polymeric carrier is not a capsule |
| 01/02/2003 | US20030003074 Comprising a biodegradable block copolymeric drug carrier having thermally reversible gelation properties; sustained release of an interleukin-2, no side effects |
| 01/02/2003 | US20030003060 Method for lubricating and protecting the oral cavity |
| 01/02/2003 | US20030003058 Freeze-dried pantoprazole preparation and pantoprazole injection |
| 01/02/2003 | US20030003055 Shaking an aqueous solution comprising a phospholipid and a polymer, in the presence of a gas, at a temperature below the gel state to liquid crystalline transition temperature of the lipid |
| 01/02/2003 | US20030003048 Useful in detecting and/or treating tumors or biological receptors |
| 01/02/2003 | US20030000518 Delivery of nonsteroidal antiinflammatory drugs through an inhalation route |
| 01/02/2003 | EP1270733A1 Method for introducing a nucleic acid into a eukaryotic cell |
| 01/02/2003 | EP1270642A1 Branched polyalkylene glycols |
| 01/02/2003 | EP1270586A2 Composition for the cell-specific transfer of active substances |
| 01/02/2003 | EP1270580A1 Antimicrobial acesulfame complexes, their preparation and their use |
| 01/02/2003 | EP1270574A1 Caffeine complexes with improved flavour, process for their preparation and their use |
| 01/02/2003 | EP1270573A1 Xanthine and phenazone acesulfam-H complexes with improved taste, process for their preparation and their use |
| 01/02/2003 | EP1270032A1 Device for parenterally delivering solid drug compositions |
| 01/02/2003 | EP1270015A2 A complex comprising OCIF and Polysaccharide |
| 01/02/2003 | EP1270014A1 Biodegradable semi-solid injectable composition assuring a particular release profile |
| 01/02/2003 | EP1270005A2 Formulation comprising amoxicillin and an organic acid |
| 01/02/2003 | EP1269997A1 Unit dosage comprising amoxicillin and clavulanate |
| 01/02/2003 | EP1269996A1 Unit dosage comprising amoxycillin and clavulanate |
| 01/02/2003 | EP1269994A2 Pharmaceutical compositions comprising drug and concentration-enhancing polymers |
| 01/02/2003 | EP1269984A1 Cosmetic and/or dermatological andor pharmaceutical composition for topical application containing at least one compound inhibiting 3-beta-HSD enzyme |
| 01/02/2003 | EP1269972A1 Hair growth stimulant compositions with sustained action |
| 01/02/2003 | EP1269195A2 Methods for identifying and isolating tissue-specific lumen-exposed molecules |
| 01/02/2003 | EP1268854A1 High specificity marker detection |
| 01/02/2003 | EP1268836A2 Novel sperm-dna complexes for genetically modifying non-human animals |
| 01/02/2003 | EP1268800A2 Mucin-1 specific binding members and methods of use thereof |
| 01/02/2003 | EP1268609A2 Method for preparing functionalised polyalkylenimines, composition containing same and uses thereof |
| 01/02/2003 | EP1268555A2 Ligands directed to the non-secretory component, non-stalk region of pigr and methods of use thereof |
| 01/02/2003 | EP1268550A2 Human fap-alpha-specific antibodies |
| 01/02/2003 | EP1268524A2 Binding peptides for carcinoembryonic antigen (cea) |
| 01/02/2003 | EP1268430A1 Chemical complex compprising a pyridine carboxy derivative and an h2 histamine receptor antagonist |
| 01/02/2003 | EP1267999A1 Stable thyroid hormone preparations and method of making same |
| 01/02/2003 | EP1267956A2 Injectable microspheres for dermal augmentation and tissue bulking |
| 01/02/2003 | EP1267946A2 Nanocapsule encapsulation system and method |
| 01/02/2003 | EP1267943A2 Medicament for the stimulation of leucopoiesis and treatment of tumour and protozoan diseases acarinosis and arthropod-borne diseases and a method for production thereof |
| 01/02/2003 | EP1267942A2 Chemically modified novel erythropoietin stimulating protein compositions and methods |
| 01/02/2003 | EP1267941A1 Alprazolam inclusion complexes and pharmaceutical compositions thereof |
| 01/02/2003 | EP1267940A1 Compounds for targeting |
| 01/02/2003 | EP1267939A2 Polyglutamic acid-camptothecin conjugates and methods of preparation |
| 01/02/2003 | EP1267938A1 Proteins for use as carriers in conjugate vaccines |
| 01/02/2003 | EP1267937A1 Polysaccharide-polypeptide conjugate |
| 01/02/2003 | EP1267936A2 Camptothecin complexes |
| 01/02/2003 | EP1267935A2 Novel treatment for eye disease |